Toxicological risk assessment demonstrates safety clearance for nonanoyl 4-hydroxy-3-methoxybenzylamide across human and environmental endpoints, indicating low hazard in consumer fragrance use.
• Nonanoyl 4-hydroxy-3-methoxybenzylamide; a safety assessment based on RIFM's criteria. • A safety assessment based on 7 human health endpoints plus environmental. • All endpoints were cleared using target data, read-across, and/or TTC.
No takes yet. Share an insight, caveat, or question.
Api et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: